c‐Met is a receptor tyrosine kinase expressed on the surface of epithelial and endothelial cells and is activated in various tumor types as a result of gain‐of‐function MET mutations, MET amplification, and c‐Met overexpression.1 This evidence concerns the gene MET and neoplasm.